CLBFX
Price
$40.96
Change
+$0.10 (+0.24%)
Updated
Jun 2 closing price
Net Assets
278.87B
MBNAX
Price
$32.74
Change
+$0.04 (+0.12%)
Updated
Jun 2 closing price
Net Assets
444.89M
Interact to see
Advertisement

CLBFX vs MBNAX

Header iconCLBFX vs MBNAX Comparison
Open Charts CLBFX vs MBNAXBanner chart's image
CLBFX vs MBNAX Comparison Chart in %
View a ticker or compare two or three
VS
CLBFX vs. MBNAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Hold and MBNAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 279B vs. MBNAX (445M). CLBFX (1.92) and MBNAX (1.88) have matching dividends . CLBFX was incepted earlier than MBNAX: CLBFX (24 years) vs MBNAX (22 years). MBNAX (1.07) is less costly to investors than CLBFX (0.66). MBNAX is a more actively managed with annual turnover of: 201.00 vs. CLBFX (50.00). CLBFX has a lower initial minimum investment than MBNAX: CLBFX (250) vs MBNAX (15000). CLBFX annual gain was more profitable for investors over the last year : 17.91 vs. MBNAX (8.88). CLBFX return over 5 years is better than : 38.25 vs. MBNAX (-1.72).
CLBFXMBNAXCLBFX / MBNAX
Total Expense Ratio0.661.0563%
Annual Report Gross Expense Ratio0.661.0762%
Fund Existence24 years22 years-
Gain YTD9.7864.860201%
Front LoadN/A3%-
Min. Initial Investment250150002%
Min. Initial Investment IRAN/AN/A-
Net Assets279B445M62,697%
Annual Yield % from dividends1.921.88102%
Returns for 1 year17.918.88202%
Returns for 3 years46.1723.53196%
Returns for 5 years38.25-1.72-2,225%
Returns for 10 years101.6319.70516%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMS71.851.27
+1.80%
CMS Energy Corp
NCPL0.90N/A
+0.17%
NETCAPITAL INC.
HWKN156.65-1.24
-0.79%
Hawkins
BAER2.20-0.02
-0.90%
Bridger Aerospace Group Holdings
CTMX3.15-0.30
-8.70%
CytomX Therapeutics